ORCL delivered a strong performance this week, with shares climbing 11.1% over seven days to close at $181.17.

ORCL delivered a strong performance this week, with shares climbing 11.1% over seven days to close at $181.17. The rally pushed the stock's one-month gain to 21%. Short interest declined 12.1% week-over-week, suggesting bearish traders are retreating as momentum builds.

Key Metrics

Market Cap: $521.1B
Short Interest: 1.68% of free float
Cost to Borrow: 0.39%
Days to Cover: 0.43
Put/Call Ratio: 0.77 (bullish sentiment)
RSI (14-day): 70.09 (approaching overbought)

Technical & Sentiment

Oracle's PCR sits well below its 20-day average of 0.89, signaling increased call buying and bullish options positioning. The z-score of -1.25 confirms this shift toward optimism. With utilization at just 0.97%, short sellers face minimal pressure, yet they're covering anyway—a sign of capitulation.

The stock's RSI near 70 indicates strong momentum but also suggests limited upside before a potential pullback. Days to cover at 0.43 means shorts can exit quickly, reducing squeeze potential.

ORTEX Stock Scores

Oracle earns solid marks across the board:

• Total Score: 81.1 (strong overall)
• Growth: 65.9
• Quality: 67.4
• Value: 46.6
• Momentum: 39.3

The quality and growth scores reflect Oracle's stable fundamentals and cloud expansion. Momentum lags despite recent price action, while the value score suggests shares trade above historical norms.

Analyst Outlook

Analysts project 34.6% upside from current levels, pointing to a consensus view that Oracle's cloud transformation justifies higher valuations. Next earnings are scheduled for June 8, 2026.

Bottom Line

Oracle's rally has legs, supported by declining short interest and strong options sentiment. The low SI% and minimal CTB mean this isn't a squeeze play—just solid momentum. Watch for consolidation near resistance as RSI approaches overbought territory. The stock offers 1.08% forward yield for those seeking income alongside growth.

This is not financial advice. ORTEX data may contain errors. Always conduct your own research before making investment decisions.